The Politics of Drug Safety: An FDA Whistleblower's Push for Reform
This article was originally published in RPM Report
Executive Summary
FDA official David Graham went on Capitol Hill to discuss his view of what's wrong with the drug safety review process. He gained acclaim during the Vioxx aftermath, and proved he still has an avid following in Congress.